tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Aquestive Therapeutics Inc

AQST
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
4.780USD
+0.170+3.69%
์ข…๊ฐ€ย 09-18 16:00๏ผˆET๏ผ‰
598.69M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

AQST ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Aquestive Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
598.69M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-7.83
์ฃผ๋‹น์ˆœ์ด์ต
-0.61
์ˆ˜์ต
44.55M
์ˆœ์ด์ต
-44.14M
ROE
0.00%
ROA
-56.63%

Aquestive Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 11, 2026
EPS / ์˜ˆ์ƒ
-0.18/-0.10
์ˆ˜์ต / ์˜ˆ์ƒ
13.82M/11.42M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-34.11%-0.18
72.63%-0.07
-39.54%-0.26
-10.54%-0.14
-351.81%-0.14
-37.79%-0.24
-55.03%-0.19
-301.65%-0.13
70.11%-0.03
-220.16%-0.17
46.84%-0.12
---0.03
---0.10
--0.15
---0.23
---0.90
----
----
----
----
์ˆ˜์ต
38.15%13.82M
65.67%14.45M
9.67%13.02M
-5.43%12.81M
-50.23%10.00M
-27.65%8.72M
-10.14%11.87M
4.15%13.54M
51.79%20.10M
8.25%12.05M
23.63%13.21M
13.43%13.00M
-0.18%13.24M
-9.26%11.13M
-3.57%10.68M
-13.73%11.46M
-13.55%13.27M
10.32%12.27M
54.96%11.08M
60.86%13.29M
์ˆœ์ด์ต
-68.76%-22.86M
64.86%-8.06M
-86.81%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-110.27%-17.05M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.30M
9.90%-13.22M
-42.11%-28.95M
12.06%-14.55M
์ˆœ์ด์ต๋ฅ 
-22.16%-165.45%
78.79%-55.77%
-70.33%-244.79%
-41.91%-120.61%
-891.69%-135.44%
-147.07%-262.96%
-134.00%-143.72%
-443.00%-84.99%
68.78%-13.66%
-246.88%-106.43%
46.88%-61.42%
---15.65%
---43.74%
--72.46%
---115.63%
---113.68%
----
----
----
----
์ด ์ด์ต๋ฅ 
30.38%70.93%
30.74%75.99%
-10.91%55.16%
-3.60%64.82%
-29.78%54.40%
-8.60%58.12%
-4.12%61.91%
6.56%67.24%
54.88%77.48%
10.67%63.59%
28.27%64.57%
--63.10%
--50.03%
--57.45%
--50.34%
--61.94%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
185.05%106.54%
176.18%91.24%
145.84%78.84%
165.99%75.66%
46.37%37.38%
48.66%33.03%
-33.11%32.07%
-56.82%28.45%
-62.84%25.53%
-67.87%22.22%
-47.53%47.95%
--65.87%
--68.71%
--69.17%
--91.38%
--102.03%
----
----
----
----
์ˆ˜์ต
38.15%13.82M
65.67%14.45M
9.67%13.02M
-5.43%12.81M
-50.23%10.00M
-27.65%8.72M
-10.14%11.87M
4.15%13.54M
51.79%20.10M
8.25%12.05M
23.63%13.21M
13.43%13.00M
-0.18%13.24M
-9.26%11.13M
-3.57%10.68M
-13.73%11.46M
-13.55%13.27M
10.32%12.27M
54.96%11.08M
60.86%13.29M
์˜์—… ์ด์ต
27.67%-8.22M
78.29%-4.20M
-112.38%-28.84M
-38.47%-11.48M
-20769.09%-11.37M
-116.20%-19.36M
-247.20%-13.58M
-248.76%-8.29M
101.31%55.00K
-94.51%-8.96M
63.49%-3.91M
73.15%-2.38M
67.02%-4.21M
52.71%-4.61M
8.19%-10.71M
-11.11%-8.85M
-95.83%-12.76M
-14.23%-9.74M
25.42%-11.67M
42.18%-7.97M
์ˆœ์ด์ต
-68.76%-22.86M
64.86%-8.06M
-86.81%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-110.27%-17.05M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.30M
9.90%-13.22M
-42.11%-28.95M
12.06%-14.55M
์œ ๋™์ž์‚ฐ
45.00%118.49M
46.00%130.18M
69.20%149.27M
57.06%151.67M
-21.43%81.72M
-21.35%89.17M
115.35%88.22M
127.45%96.57M
161.41%104.01M
159.41%113.38M
2.70%40.97M
11.47%42.46M
-8.54%39.79M
2.63%43.71M
-15.60%39.89M
-24.14%38.09M
-14.69%43.51M
-4.18%42.59M
5.90%47.26M
58.47%50.21M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-28.84%16.48M
73.53%31.75M
152.36%47.61M
68.78%25.57M
66.64%23.16M
1.33%18.30M
3.04%18.86M
-37.02%15.15M
-64.05%13.89M
-55.28%18.06M
-53.68%18.31M
-34.20%24.06M
30.43%38.65M
66.98%40.38M
79.97%39.53M
46.01%36.56M
28.66%29.64M
20.62%24.18M
4.08%21.96M
36.28%25.04M
์ด ์ž์‚ฐ
40.99%132.10M
38.04%141.13M
58.17%160.43M
48.75%163.56M
-20.33%93.70M
-21.07%102.23M
76.64%101.42M
84.97%109.96M
106.35%117.61M
111.35%129.52M
0.61%57.42M
14.66%59.45M
1.21%56.99M
8.41%61.28M
-7.94%57.07M
-20.60%51.84M
-15.80%56.31M
-8.71%56.53M
-1.42%61.99M
29.49%65.29M
๋ถ€์ฑ„ ์ด๊ณ„
13.47%188.69M
7.36%175.18M
20.12%194.09M
7.91%167.67M
8.63%166.29M
-1.60%163.16M
-1.42%161.58M
-4.31%155.38M
-6.45%153.08M
-2.75%165.82M
-6.67%163.91M
1.70%162.38M
7.19%163.65M
13.93%170.52M
21.85%175.62M
27.08%159.66M
26.54%152.67M
31.61%149.67M
29.40%144.13M
44.51%125.64M
์ž๋ณธ ์ด๊ณ„
22.05%-56.59M
44.11%-34.05M
44.04%-33.66M
90.95%-4.11M
-104.60%-72.59M
-67.85%-60.93M
43.51%-60.16M
55.87%-45.42M
66.73%-35.48M
66.77%-36.30M
10.18%-106.49M
4.54%-102.93M
-10.68%-106.65M
-17.28%-109.23M
-44.34%-118.55M
-78.67%-107.82M
-79.21%-96.36M
-79.82%-93.14M
-69.36%-82.13M
-65.24%-60.34M
์ˆœ์˜์—…์ด์ต
-19.29%-9.44M
36.73%-14.81M
-30.51%-8.47M
-6.47%-12.65M
-12.96%-7.91M
-125.35%-23.40M
-31.30%-6.49M
-406.18%-11.88M
11.39%-7.01M
-217.79%-10.38M
-158.51%-4.94M
-183.55%-2.35M
-20.50%-7.91M
160.88%8.82M
204.78%8.45M
130.99%2.81M
-273.69%-6.56M
-2.73%-14.48M
40.34%-8.06M
-9.05%-9.06M
์ˆœํˆฌ์ž
-98.13%-212.00K
61.48%-52.00K
-466.67%-85.00K
-193.75%-235.00K
-205.71%-107.00K
-365.52%-135.00K
6.25%-15.00K
47.02%-80.00K
95.76%-35.00K
-1350.00%-29.00K
38.46%-16.00K
91.21%-151.00K
-22.01%-826.00K
98.08%-2.00K
95.12%-26.00K
-1968.67%-1.72M
-248.97%-677.00K
-0.97%-104.00K
-125.85%-533.00K
-118.42%-83.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
-2491.00%-2.59M
-78.58%4.42M
320.38%660.00K
478988.24%81.41M
-105.84%-100.00K
-74.74%20.65M
-95.99%157.00K
-100.34%-17.00K
-60.09%1.71M
988.01%81.74M
1818.14%3.91M
3707.97%4.98M
-57.96%4.29M
-809.17%-9.21M
-96.26%204.00K
-102.27%-138.00K
17.41%10.20M
-86.88%1.30M
-80.86%5.45M
86928.57%6.08M

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Aquestive Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 44.55M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 57.56M์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 149.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 69.20์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aquestive Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 160.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 58.17์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aquestive Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 194.09M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 20.12์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aquestive Therapeutics Inc์˜ ์ด์ž๋ณธ์€ -33.66M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 44.04์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aquestive Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -71.05M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -130.90์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aquestive Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -562.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -253.46์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aquestive Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 102.62M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.76์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.78์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -53.97์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -83.78M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -89.83์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -188.09์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -145.29์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 58.35์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -15.38์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 78.84์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -31.34์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -63.99์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -15.15์ž…๋‹ˆ๋‹ค.

Aquestive Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aquestive Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -71.05M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -130.90์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ